EyePoint Pharmaceuticals ( NASDAQ: EYPT ) priced an underwritten public offering of ~12.73M shares at $11.00 per share.
The aggregate gross proceeds from this offering are expected to be ~$140M. All of the shares of common stock are being sold by EyePoint. The.
Business